Article

The impact of maternal depression in pregnancy on early child development

Centre for Child and Adolescent Health, University of the West of England, Bristol, UK.
BJOG An International Journal of Obstetrics & Gynaecology (Impact Factor: 3.86). 07/2008; 115(8):1043-51. DOI: 10.1111/j.1471-0528.2008.01752.x
Source: PubMed

ABSTRACT Postpartum depression in mothers is associated with developmental problems in their children. Many women who are depressed following childbirth are also depressed during pregnancy. The aim of this study was to examine the associations between maternal depressive symptoms during pregnancy and child development at 18 months of age.
A prospective cohort study, Avon Longitudinal Study of Parents and Children.
The former county of Avon, southwest England.
All pregnant women in the defined area with delivery dates between April 1991 and December 1992, 9244 women and their children.
Data were collected antenatally, at 18 and 32 weeks of gestation and at 8 weeks and 8 months postnatally, through postal questionnaires, including a self-report measure of depression (Edinburgh Postnatal Depression Scale [EPDS]). By the time their child was 18 months old, women completed five further questionnaires about their children's health and development.
Child development at 18 months using a modified Denver Developmental Screening Test (modified DDST).
Applying the standard 12/13 cutoff, 1565 (14%) women were depressed antenatally but not at either time-points postnatally. Employing the modified DDST, 893 (9%) children were developmentally delayed at 18 months of age. Persistent depression (EPDS > or = 10 at both time-points) is associated with developmental delay (adjusted OR 1.34, 95% CI 1.11-1.62). Applying the 12/13 and 14/15 cutoffs gave similar results. After further adjustment for postnatal depression, the effect sizes were slightly attenuated.
These findings highlight the importance of depression in pregnancy. Some effects on child development attributed to postpartum depression are caused in part by depressive symptoms during pregnancy.

Download full-text

Full-text

Available from: Toity Deave, Aug 15, 2015
1 Follower
 · 
146 Views
  • Source
    • "The issue of whether prenatal SSRI use or the indication for SSRI use is the risk factor remains unresolved. Associations between maternal depression, the chief indicating condition for SSRI use, and developmental psychopathology in children have been reported (Brennan et al. 2000; Caplan et al. 1989; Carter et al. 2001; Deave et al. 2008; Huot et al. 2004). Diagnoses for psychiatric disorders before the birth of the child are more common among parents of children with ASD than parents of children without a diagnosis of ASD, and maternal depression appears to be a greater risk factor than paternal depression (Bolton et al. 1998; Daniels et al. 2008; Rai et al. 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark's health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child's risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.
    Journal of Autism and Developmental Disorders 05/2014; 44(10). DOI:10.1007/s10803-014-2128-4
  • Source
    • "Up to 18.4% of women experience depression during pregnancy , and as many as 19.2% of mothers experience depression within 3 months of delivery [1]. Perinatal depression has been associated with deleterious effects on mother–child dyad and family [4] [5] [6]; it can have a negative effect on birth outcomes [7] and on infant attachment, behavior and development [4] [5]. Twenty percent of postpartum deaths in depressed women result from maternal suicide [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The objectives were to examine patients' perspectives on patient-, provider- and systems-level barriers and facilitators to addressing perinatal depression in outpatient obstetric settings. We also compare the views of patients and perinatal health care professionals. Four 90-min focus groups were conducted with women 3-36 months after delivery (n=27) who experienced symptoms of perinatal depression, anxiety or emotional distress. Focus groups were transcribed, and resulting data were analyzed using a grounded theory approach. Barriers to addressing perinatal depression included fear of stigma and loss of parental rights, negative experiences with perinatal health care providers and lack of depression management knowledge/skills among professionals. Facilitators included psychoeducation, peer support and training for professionals. Patients perceive many multilevel barriers to treatment that are similar to those found in our previous similar study of perinatal health care professionals' perspectives. However, patients and professionals do differ in their perceptions of one another. Interventions would need to close these gaps and include an empathic screening and referral process that facilitates discussion of mental health concerns. Interventions should leverage strategies identified by both patients and professionals, including empowering both via education, resources and access to varied mental health care options.
    General hospital psychiatry 08/2013; DOI:10.1016/j.genhosppsych.2013.07.011
  • Source
    • "Several animal and human studies show that maternal stress or depression disrupt fetal neurobehavioral development and affect cognitive, emotional and behavioral outcomes throughout childhood (Peters, 1990; Hayashi et al., 1998; Talge et al., 2007; Homberg et al., 2010). Children exposed to the stress induced by depressed mothers are also at increased risk of developmental delay, impaired language development, and even low IQ scores (Figure 1) (Deave et al., 2008; Paulson et al., 2009). The impact of maternal depression on newborns has effects that last beyond infancy, as onethird of school-aged children of depressed mothers suffer from depression and anxiety disorders (Pilowsky et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In addition to its role in the pathophysiology of numerous psychiatric disorders, increasing evidence points to serotonin (5-HT) as a crucial molecule for the modulation of neurodevelopmental processes. Recent evidence indicates that the placenta is involved in the synthesis of 5-HT from maternally derived tryptophan (TRP). This gives rise to the possibility that genetic and environmental perturbations directly affecting placental TRP metabolism may lead to abnormal brain circuit wiring in the developing embryo, and therefore contribute to the developmental origin of psychiatric disorders. In this review, we discuss how perturbations of the placental TRP metabolic pathway may lead to abnormal brain development and function throughout life. Of particular interest is prenatal exposure to maternal depression and antidepressants, both known to alter fetal development. We review existing evidence on how antidepressants can alter placental physiology in its key function of maintaining fetal homeostasis and have long-term effects on fetal forebrain development.
    Frontiers in Cellular Neuroscience 04/2013; 7:47. DOI:10.3389/fncel.2013.00047
Show more